clasto-lactacystin beta-lactone has been researched along with carfilzomib in 1 studies
Studies (clasto-lactacystin beta-lactone) | Trials (clasto-lactacystin beta-lactone) | Recent Studies (post-2010) (clasto-lactacystin beta-lactone) | Studies (carfilzomib) | Trials (carfilzomib) | Recent Studies (post-2010) (carfilzomib) |
---|---|---|---|---|---|
85 | 0 | 15 | 748 | 121 | 716 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arisawa, M; Asai, A; Groll, M; Kawamura, S; List, A; Mizuno, A; Sasaki, T; Shuto, S; Tanaka, M; Unno, Y | 1 |
1 other study(ies) available for clasto-lactacystin beta-lactone and carfilzomib
Article | Year |
---|---|
Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action.
Topics: Cell Proliferation; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Cyclopropanes; Drug Stability; HCT116 Cells; Humans; Intercellular Signaling Peptides and Proteins; Isomerism; Models, Molecular; Peptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Conformation; Water | 2013 |